EUVIMEDEUVIMED entdecken
Crossref

Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD

Jiahe Liu, Yuwei Zheng, Songya Yang, Lihan Zhang, Bingxue Liu, Jiexing Zhang, Xiaoqing Yu, Xiangjian Wei, Shize Li, Jianfa Wang, Hongming Lv

Phytomedicine · 2024

DOI: 10.1016/j.phymed.2024.155756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Phytomedicine, 2024. Verfasst von Jiahe Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Bovine Disease Control in Northeast China, Ministry of Agriculture and Rural affairs, Heilongjiang Provincial Key Laboratory of Pre…. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, NF-E2-Related Factor 2, Pyroptosis. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a persistent liver condition that affects both human health and animal productive efficiency on a global scale. A number of naturally occurring compounds activate nuclear factor erythroid 2-related factor 2 (Nrf2) as a transcription factor with important protective effects against many liver diseases, including NAFLD. Raffinose (Ra), an oligosaccharide extracted from several plants, exhibits diverse biological functions. However, the uncertainty lies in determining whether the activation of Nrf2 by Ra can provide a preventive effect on liver lipotoxicity. PURPOSE: The aim of this study was to shed light on the molecular pathways by which Ra possesses its protective benefits against NAFLD. METHODS: Experimental protocols were established using WT and Nrf2-null (Nrf2-/-) mice. Liver samples from each group were collected for Western blot, RT-qPCR, H & E, Sirius red and Oil red O staining. Additionally, serums were processed for ELISA. ALM12 cells were gathered for Western blot and immunofluorescence. Moreover, to elucidate the molecular mechanism of Ra, molecular docking was performed. RESULTS: Our results indicated that Ra remarkably alleviated liver lipotoxic in vivo and in vitro. Ra treatment effectively corrected hepatic steatosis, the release of AST, ALT, TG, and TC, as well as the depletion of HDL and LDL. Meanwhile, Ra efficiently prevented inflammation by inhibiting the TLR4-MyD88-NF-κB pathway and pyroptosis. Additionally, these findings implied that Ra reduced the production of fibrosis-related proteins, which enhanced collagen deposition. Molecular docking revealed that Ra possessed the ability to bind specific regions of Nrf2, resulting in the enhancement of Nrf2 activation and nuclear translocation. Ra treatment restored serum redox factors and antioxidant enzymes to normal levels; however, these alterations were clearly reversed in Nrf2-/- mice. CONCLUSION: This study reveals novel information on Ra's protective benefits against liver injury caused by abnormal lipid metabolism; these effects are mostly mediated by Nrf2 activation, suggesting a potential new medicine or treatment strategy for NAFLD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseNF-E2-Related Factor 2PyroptosisAnimalsMiceToll-Like Receptor 4MaleLipid MetabolismMice, Inbred C57BLInflammationLiverMolecular Docking SimulationAntioxidantsLiver CirrhosisMice, KnockoutSignal TransductionMyeloid Differentiation Factor 88NF-kappa B

Stichwörter der Autor:innen

InflammationNAFLDNrf2 pathwayOxidative stressRaffinose

Substanzen

NF-E2-Related Factor 2Nfe2l2 protein, mouseToll-Like Receptor 4AntioxidantsMyeloid Differentiation Factor 88NF-kappa B

Autor:innen und Institutionen

  • Key Laboratory of Bovine Disease Control in Northeast China, Ministry of Agriculture and Rural affairs, Heilongjiang Provincial Key Laboratory of Prevention and Control of Bovine Diseases, College of Animal Science and…

Zitieren

APA

Liu, J., Zheng, Y., Yang, S., Zhang, L., Liu, B., Zhang, J., Yu, X., Wei, X., Li, S., Wang, J., & Lv, H. (2024). Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD. Phytomedicine. https://doi.org/10.1016/j.phymed.2024.155756

Vancouver

Liu J, Zheng Y, Yang S, Zhang L, Liu B, Zhang J, et al. Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD. Phytomedicine. 2024. doi:10.1016/j.phymed.2024.155756

BibTeX
@article{Liu2024,
  author = {Liu, Jiahe and Zheng, Yuwei and Yang, Songya and Zhang, Lihan and Liu, Bingxue and Zhang, Jiexing and Yu, Xiaoqing and Wei, Xiangjian and Li, Shize and Wang, Jianfa and Lv, Hongming},
  title = {Targeting antioxidant factor Nrf2 by raffinose ameliorates lipid dysmetabolism-induced pyroptosis, inflammation and fibrosis in NAFLD},
  journal = {Phytomedicine},
  year = {2024},
  doi = {10.1016/j.phymed.2024.155756}
}
Kostenlos starten →